Skip to main content
. Author manuscript; available in PMC: 2012 Oct 19.
Published in final edited form as: Vaccine. 2011 Aug 22;29(45):8066–8072. doi: 10.1016/j.vaccine.2011.08.044

Figure 2.

Figure 2

Figure 2

Reverse cumulative distributions for the G9 strain by dosage and age group as measured by HAI (A and B) and MNt (C and D) for the day 28 (A and C) and day 56 (B and D) time points. Data are shown for each age group (18–38 years and 44–59 years) and dosage group (7.5 and 30 mcg).